Use of topical therapies during pregnancy and the postpartum period
ENT Diseases: Diagnosis and Treatment during Pregnancy and Lactation, Springer International Publishing Ag, ss.133-140, 2022
- Yayın Türü: Kitapta Bölüm / Araştırma Kitabı
- Basım Tarihi: 2022
- Doi Numarası: 10.1007/978-3-031-05303-0_12
- Yayınevi: Springer International Publishing Ag
- Sayfa Sayıları: ss.133-140
- Anahtar Kelimeler: Drug therapy, Otolaryngology, Postpartum period, Pregnancy, Topical administration
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Treatment selection choices during pregnancy should be based on the US Food and Drug Administration (FDA) risk categories. The FDA categorized drugs as A, B, C, D, and X based on animal and human studies. Category D and category X drugs should be avoided during pregnancy, whereas category A and category B drugs are safe to use. Category C drugs should be considered case by case as there are no adequate studies on humans, but animal studies have shown the adverse effects on fetus.